Serotonin 1B and 2C Receptor Interactions in the Modulation of Feeding Behaviour in the Mouse
Overview
Affiliations
Rationale: To examine the functional relationship between 5-HT1B receptors (5-HT1B-R) and 5-HT2C receptors (5-HT2C-R) in the control of food intake.
Objectives: To compare the hypophagic effect of the 5-HT(2C/1B)-R agonist m-chlorophenylpiperazine (mCPP), with that of the selective 5-HT1B-R agonist CP-94,253 in both wildtype (WT) and 5-HT2C knockout (KO) mice.
Methods: The hypophagic effects of mCPP (1, 3 and 5.6 mg/kg) and CP-94,253 (5, 10 and 20 mg/kg) were assessed in WT and 5-HT2C KO mice using the behavioural satiety sequence paradigm. The effects of pre-treatment with the selective 5-HT2C-R antagonist SB 242,084 (0.5 and 1.5 mg/kg) were assessed in two groups of WT mice, with each group given only mCPP or CP-94,253.
Results: The 5-HT(2C/1B) receptor agonist mCPP and the selective 5-HT1B receptor agonist CP-94,253 both suppressed food intake in WT mice. 5-HT2C KO mice were insensitive to the hypophagic effects of mCPP but were more sensitive to CP-94,253-induced hypophagia than WT controls. mCPP induced a significant increase in post-prandial activity in 5-HT2C KO mice, but this effect was absent in 5-HT2C KO mice who were given CP-94,253. Data from WT mice, who were pre-treated with the 5-HT2C receptor antagonist SB 242,084 and then challenged with either mCPP or CP-94,253, were similar to those obtained from 5-HT2C KO mice.
Conclusions: 5-HT2C-R and 5-HT1B-R activation are each sufficient to induce a hypophagic response. However, concurrent 5-HT2C-R inactivation can potentiate the hypophagic response to 5-HT1B-R activation, consistent with an inhibitory role for the 5-HT2C-R in behaviour mediated by the activation of other 5-HT receptors. These results also confirm that 5-HT1B-R activation alone cannot account for the hyperactive response of 5-HT2C KO mice to mCPP.
Nonogaki K Int J Mol Sci. 2022; 23(3).
PMID: 35163521 PMC: 8836087. DOI: 10.3390/ijms23031600.
Central 5-HTR2C in the Control of Metabolic Homeostasis.
Yao T, He J, Cui Z, Wang R, Bao K, Huang Y Front Endocrinol (Lausanne). 2021; 12:694204.
PMID: 34367066 PMC: 8334728. DOI: 10.3389/fendo.2021.694204.
Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.
PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.
Tysseling V, Klein D, Imhoff-Manuel R, Manuel M, Heckman C, Tresch M J Neurophysiol. 2017; 118(5):2944-2952.
PMID: 28877964 PMC: 5686237. DOI: 10.1152/jn.00190.2017.
Palacios J, Pazos A, Hoyer D Psychopharmacology (Berl). 2017; 234(9-10):1395-1418.
PMID: 28265714 DOI: 10.1007/s00213-017-4545-5.